Article Text

Download PDFPDF
Economic Impact Among Family Caregivers of Patients With Advanced Ovarian Cancer
  1. Roberto Angioli, MD,
  2. Stella Capriglione, MD,
  3. Alessia Aloisi, MD,
  4. Andrea Miranda, MD,
  5. Carlo de Cicco Nardone, MD,
  6. Corrado Terranova, MD,
  7. Roberto Adrower, MD and
  8. Francesco Plotti, MD
  1. Department of Obstetrics and Gynaecology, Campus Bio Medico, University of Rome, Rome, Italy.
  1. Address correspondence and reprint requests to Roberto Angioli, MD, Department of Obstetrics and Gynecology, University of Rome “Campus Bio-Medico,” Via Alvaro del Portillo, 200-00128 Rome, Italy. E-mail: r.angioli@unicampus.it.

Abstract

Objectives The life of a family caregiver changes in many ways when cancer is diagnosed. Changes regard also financial costs. To the authors’ knowledge, little work has been done to estimate the costs associated with caregiving for cancer patients. The aim of the present study is to evaluate for the first time in literature the economic changes among family caregivers of advanced ovarian cancer during the first-line treatment in an Italian survey.

Methods Between January 2009 and June 2014, the primary family caregivers of patients with advanced ovarian cancer (N = 172) were recruited from to the Division of Gynecologic Oncology of the University Campus Bio-Medico of Rome within 4 weeks of the patient’s new diagnosis. Caregivers reported demographic, medical information, and economic cost, such as traveling to and from medical appointments, waiting with patients for appointments, missing work, and attending to patients who are hospitalized.

Results Between January 2009 and June 2014, 172 primary family caregivers of patients with advanced ovarian cancer were enrolled in the study. The mean age of the study cohort was 54.01 years. They reported 3% of missing workdays. The mean cost for all caregivers was &OV0556;1,888,732 per year. Therefore, the mean cost for each caregiver was &OV0556;10,981 annually.

Conclusions This economic analysis of caregiving in patients with advanced ovarian cancer reports the significant burden that cancer treatment places on both families and society. These findings underscore the importance, when appropriate, of including valid estimates of the cost of informal caregiving when evaluating the cost-effectiveness of cancer treatments.

  • Caregiving
  • Economic impact
  • Ovarian cancer

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.